OPPENHEIMER ASSET MANAGEMENT INC. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$2,849,301
+23.9%
17,919
+10.2%
0.04%
+29.4%
Q2 2023$2,299,291
+259.3%
16,254
+327.6%
0.03%
+240.0%
Q1 2023$639,937
-0.6%
3,801
-0.1%
0.01%0.0%
Q4 2022$643,886
-13.6%
3,803
-4.5%
0.01%
-23.1%
Q3 2022$745,000
+0.5%
3,983
-12.7%
0.01%
+8.3%
Q2 2022$741,000
-83.6%
4,560
-81.0%
0.01%
-81.2%
Q1 2022$4,506,000
-16.2%
23,954
+18.1%
0.06%
-9.9%
Q4 2021$5,374,000
-11.0%
20,289
-2.9%
0.07%
-17.4%
Q3 2021$6,036,000
+667.9%
20,887
+430.7%
0.09%
+681.8%
Q2 2021$786,000
+3.0%
3,936
+0.2%
0.01%
-8.3%
Q1 2021$763,000
+3.5%
3,927
+2.1%
0.01%0.0%
Q4 2020$737,000
+35.7%
3,845
+4.4%
0.01%
+9.1%
Q3 2020$543,000
+26.3%
3,682
+5.9%
0.01%
+22.2%
Q2 2020$430,000
+66.7%
3,477
+29.8%
0.01%
+50.0%
Q1 2020$258,000
+33.7%
2,679
+28.7%
0.01%
+50.0%
Q4 2019$193,000
+16.3%
2,082
-3.8%
0.00%0.0%
Q3 2019$166,000
-12.6%
2,165
-2.5%
0.00%0.0%
Q2 2019$190,000
+34.8%
2,221
-6.9%
0.00%
+33.3%
Q1 2019$141,000
+28.2%
2,385
+14.0%
0.00%0.0%
Q4 2018$110,000
-2.7%
2,093
-28.9%
0.00%0.0%
Q3 2017$113,000
-8.1%
2,942
-0.7%
0.00%0.0%
Q2 2017$123,0002,9620.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders